These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pathology of wild-type and toxin-independent Bacillus anthracis meningitis in rabbits. Sittner A; Bar-David E; Glinert I; Ben-Shmuel A; Weiss S; Schlomovitz J; Kobiler D; Levy H PLoS One; 2017; 12(10):e0186613. PubMed ID: 29088287 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849 [TBL] [Abstract][Full Text] [Related]
29. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216 [TBL] [Abstract][Full Text] [Related]
30. Anthrax: safe treatment for children. Benavides S; Nahata MC Ann Pharmacother; 2002 Feb; 36(2):334-7. PubMed ID: 11847958 [TBL] [Abstract][Full Text] [Related]
31. Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin. Vietri NJ; Tobery SA; Chabot DJ; Ingavale S; Somerville BC; Miller JA; Schellhase CW; Twenhafel NA; Fetterer DP; Cote CK; Klimko CP; Boyer AE; Woolfitt AR; Barr JR; Wright ME; Friedlander AM J Infect Dis; 2021 Feb; 223(2):319-325. PubMed ID: 32697310 [TBL] [Abstract][Full Text] [Related]
32. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test. Madhusudhan KT; Counts C; Lody C; Carter O; Dodson S; Ojha N Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053 [TBL] [Abstract][Full Text] [Related]